Site-Specific Drug Delivery Market, By Application (Pulmonary, Ocular, Oncology, CNS, Cardiovascular) - World Forecasts to 2022 - Product Thumbnail Image

Site-Specific Drug Delivery Market, By Application (Pulmonary, Ocular, Oncology, CNS, Cardiovascular) - World Forecasts to 2022

  • Report
  • 75 Pages
From
Prostate Cancer - Pipeline Review, H2 2017 - Product Thumbnail Image

Prostate Cancer - Pipeline Review, H2 2017

  • Report
  • 1878 Pages
From
Prostate Cancer - Pipeline Review, H1 2017 - Product Thumbnail Image

Prostate Cancer - Pipeline Review, H1 2017

  • Report
  • 1845 Pages
From
Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016 - Product Thumbnail Image

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

  • Report
  • 463 Pages
From
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016 - Product Thumbnail Image

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

  • Report
  • 665 Pages
From
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016 - Product Thumbnail Image

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

  • Report
  • 663 Pages
From
Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016 - Product Thumbnail Image

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

  • Report
  • 430 Pages
From
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015 - Product Thumbnail Image

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015

  • Report
  • 654 Pages
From
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015 - Product Thumbnail Image

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

  • Report
  • 322 Pages
From
Non-Small Cell Lung Cancer - Pipeline Review, H1 2017 - Product Thumbnail Image

Non-Small Cell Lung Cancer - Pipeline Review, H1 2017

  • Report
  • 2437 Pages
From
Uveitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Uveitis - Pipeline Review, H1 2018

  • Report
  • 195 Pages
From
Rheumatoid Arthritis - Pipeline Review, H2 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2017

  • Report
  • 1051 Pages
From
Rheumatoid Arthritis - Pipeline Review, H1 2017 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H1 2017

  • Report
  • 1020 Pages
From
Endocyte, Inc. - Product Pipeline Review - 2015 - Product Thumbnail Image

Endocyte, Inc. - Product Pipeline Review - 2015

  • Company Profile
  • 46 Pages
From
Ovarian Cancer - Pipeline Review, H2 2017 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H2 2017

  • Report
  • 2232 Pages
From
Ovarian Cancer - Pipeline Review, H1 2017 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H1 2017

  • Report
  • 2027 Pages
From
Breast Cancer - Pipeline Review, H1 2016 - Product Thumbnail Image

Breast Cancer - Pipeline Review, H1 2016

  • Report
  • 3011 Pages
From
Polycystic Kidney Disease - Pipeline Review, H1 2018 - Product Thumbnail Image

Polycystic Kidney Disease - Pipeline Review, H1 2018

  • Report
  • 108 Pages
From
Polycystic Kidney Disease - Pipeline Insight, 2018 - Product Thumbnail Image

Polycystic Kidney Disease - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Q1 2017 Earnings Call - Endocyte, Inc., - Earnings Transcript - Product Thumbnail Image

Q1 2017 Earnings Call - Endocyte, Inc., - Earnings Transcript

  • Earnings Transcript
Loading Indicator
adroll